Publication | Closed Access

A decision model to compare health care costs of olanzapine and risperidone treatment for schizophrenia in Germany

Psychiatric EvaluationHealth PolicyHealth EconomicsPsychiatryRisperidone TreatmentPsychotic DisorderHealth InsuranceOutcomes ResearchSchizophreniaDecision ModelPharmacoeconomicsHealth Care CostPublic HealthEconomic EvaluationMedicineHealth Services ResearchHealth Care Costs